Biotechnology
Company Overview of Virionics Corporation
Company Overview
Virionics Corporation operates as a biotechnology company. The company offers development, marketing, and commercialization of antigen presentation platform for the prevention and treatment of infectious diseases, cancers, and inflammatory diseases in the United States. Its products include PapviRx, an human papillomavirus therapeutic vaccine for the treatment of cervical dysplasia, and metastatic cervical cancer in women; HepCVax, an hepatitis C virus vaccine (HCV) for the prevention of HCV infection, and treatment of chronic HCV diseases; and RetroVax human immunodeficiency virus (HIV) vaccine to prevent HIV infection. The company was founded in 2003 and is based in Scottsdale, Arizona.
8643 East Preserve Way
Scottsdale, AZ 85266-1320
United States
Founded in 2003
Key Executives for Virionics Corporation
Similar Private Companies By Industry
| Company Name | Region |
| Virium Pharmaceuticals Inc. | United States |
| Clinical Trials Services, Inc. | United States |
| Innocoll, Inc. | United States |
| D-finitive Technologies, Inc. | United States |
| ProMed Pharma, LLC | United States |
Recent Private Companies Transactions
| Type Date |
Target | |
| No transactions available in the past 12 months. | ||
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Greater Houston Partnership | United States |
Post a JobJobs
- New York, NY | Robert W. BairdPosted: Apr 21
- Efland, NC | Orange County SchoolsPosted: May 19
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
- New Haven, CT | Umami BurgerPosted: Apr 04
Sponsored Financial Commentaries
Sponsored Links
To contact Virionics Corporation, please visit www.virionics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
